Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| H CYTE Inc (QB) | HCYT | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.995 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.995 | 0.995 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.5002 - 3.7315 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.995 | USD |
H CYTE Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.55M | 661.35k | 59.02k | 453k | -10.3M | -0.02 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
H CYTE (QB) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/02/2024 | 13:41 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
| 4/01/2024 | 11:56 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/06/2024 | 07:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/06/2024 | 15:00 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 1/18/2024 | 15:17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/21/2023 | 16:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/15/2023 | 07:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/15/2023 | 07:11 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 10/03/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/11/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HCYT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 1.28 | 3.7315 | 0.5002 | 1.64 | 1,723 | -0.285 | -22.27% |
| 3 Years | 0.0467 | 7.00 | 0.01 | 0.0580062 | 137,910 | 0.9483 | 2,030.62% |
| 5 Years | 0.50 | 7.00 | 0.006 | 0.071555 | 91,729 | 0.495 | 99.00% |
H CYTE (QB) Description
| H-CYTE is a hybrid-biopharmaceutical company dedicated to developing and delivering a novel portfolio of new diagnostics, therapeutics, and medical devices from concept to commercialization. |
